Jan 8, 2026 08:37AM
Jan 8, 2026 08:30AM
Nov 13, 2025 05:02PM
Nov 13, 2025 07:30AM
Aug 14, 2025 07:30AM
May 8, 2025 05:22PM
May 8, 2025 07:30AM Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2025 Financial Results
Mar 11, 2025 07:32AM
Mar 11, 2025 07:30AM
Nov 7, 2024 09:06AM
Nov 7, 2024 09:05AM
Aug 8, 2024 08:55AM
Aug 8, 2024 07:30AM
May 14, 2024 07:30AM Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
Apr 1, 2024 04:05PM
Mar 28, 2024 07:02AM
Mar 28, 2024 07:00AM
Nov 9, 2023 04:01PM
Aug 14, 2023 07:30AM
Aug 14, 2023 07:30AM
May 9, 2023 07:30AM Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2023 Financial Results
Mar 2, 2023 04:05PM
Mar 2, 2023 04:05PM
Nov 9, 2022 07:31AM
Nov 9, 2022 07:30AM
Nov 9, 2022 07:30AM
Aug 9, 2022 07:30AM
Aug 9, 2022 07:30AM Xilio Therapeutics Announces Encouraging Preliminary Phase 1 Dose-Escalation Data for XTX101, a Tumor-Selective Anti-CTLA-4, and Reports Pipeline and Business Updates and Second Quarter 2022 Financial
Aug 9, 2022 07:30AM
May 12, 2022 07:31AM
May 12, 2022 07:30AM
May 12, 2022 07:30AM
Mar 1, 2022 06:30AM
Mar 1, 2022 06:30AM
Dec 2, 2021 07:33AM Xilio Therapeutics (XLO) Announces Pipeline Updates, Reports Q3 Reults
Dec 2, 2021 07:30AM
Dec 2, 2021 07:30AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All